Incidence of late onset neutropenia associated with rituximab use in B cell lymphoma patients undergoing autologous stem cell transplantation.

Ha, Vincent H; Ghosh, Sunita; Leyshon, Catherine; Ryan, Nikki; Chambers, Carole R; Stewart, Douglas A

Ha, Vincent H; Ghosh, Sunita; Leyshon, Catherine; Ryan, Nikki; Chambers, Carole R; Stewart, Douglas A.

Afiliação

Ha VH; 1 Department of Pharmacy, Cross Cancer Institute, Edmonton, Canada.
Ghosh S; 2 Department of Pharmacy, Tom Baker Cancer Centre, Calgary, Canada.
Leyshon C; 3 Department of Experimental Oncology, Cross Cancer Institute, Edmonton, Canada.
Ryan N; 2 Department of Pharmacy, Tom Baker Cancer Centre, Calgary, Canada.
Chambers CR; 2 Department of Pharmacy, Tom Baker Cancer Centre, Calgary, Canada.
Stewart DA; 2 Department of Pharmacy, Tom Baker Cancer Centre, Calgary, Canada.

J Oncol Pharm Pract ; 24(5): 323-331, 2018 Jul.

Article em En | MEDLINE | ID: mdl-28358279

Assuntos

Transplante de Células-Tronco Hematopoéticas/métodos; Linfoma de Células B/terapia; Neutropenia/epidemiologia; Rituximab/efeitos adversos; Adulto; Idoso; Feminino; Humanos; Incidência; Masculino; Pessoa de Meia-Idade; Estudos Retrospectivos; Rituximab/uso terapêutico; Transplante Autólogo; Adulto Jovem

Palavras-chave

B cell lymphoma; Late onset neutropenia; autologous stem cell transplant; rituximab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Transplante de Células-Tronco Hematopoéticas / Rituximab / Neutropenia Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google